Bristol-Myers Squibb Establishes Center for Molecular Synthesis in New Collaboration with Princeton University

Primary tabs

Bristol-Myers Squibb Establishes Center for Molecular Synthesis in New Collaboration with Princeton University

Tuesday, December 8, 2015 - 4:10pm

CAMPAIGN: Advancing Science Through Research

CONTENT: Press Release

Tuesday, December 8, 2015 4:10 pm EST, PRINCETON, N.J. /3BL Media/ - Bristol-Myers Squibb Company (NYSE:BMY) and the Department of Chemistry at Princeton University today announced a new research collaboration, which includes the establishment of the Center for Molecular Synthesis (BMS-CMS). The agreement creates opportunities for scientists at Princeton University and Bristol-Myers Squibb to collaborate on top-flight synthetic chemistry research, leveraging the two sites’ close proximity to foster a robust exchange of scientific ideas.

“Bristol-Myers Squibb has a long history of engaging in external collaborations and partnerships of all shapes and sizes, always with an eye toward advancing science,” said Percy Carter, Ph.D, head of discovery chemistry, Bristol-Myers Squibb. “Similarly, the Department of Chemistry at Princeton University fosters an environment of collegiality, innovation and scientific rigor, and our scientists look forward to contributing to that through this research collaboration.”

“We are very excited about working with Bristol-Myers Squibb and its scientists as it will empower the faculty in the Department of Chemistry at Princeton who are involved in the collaboration to do out-of-the-box research,” said Pablo Debenedetti, the Dean for Research at Princeton University.

The research projects will investigate areas of mutual interest and benefit, utilizing the expertise developed in the laboratories of the Princeton faculty to conduct frontier science within the pharmaceutical industry. Over the next five years, the Center will also fund a select group of research fellows each year. Each research fellow will be paired with a Bristol-Myers Squibb mentor who will provide scientific guidance to the researcher and offer valuable input from an industrial chemistry perspective. Fellows will also be able to interact with a variety of industrial researchers and learn firsthand how research is conducted in a pharmaceutical setting.

Financial terms of the agreement were not disclosed.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.

About the Department of Chemistry at Princeton University

The Department of Chemistry at Princeton University is a hub for cutting edge academic research where chemistry and other disciplines merge. For more information, please visit www.chemistry.princeton.edu or follow us on Twitter at https://twitter.com/PrincetonChem.

 

Contact:

Bristol-Myers Squibb
Media:
Sarah Koenig, 609-252-4145
sarah.koenig@bms.com
or
Investors:
Ranya Dajani, 609-252-5330
ranya.dajani@bms.com
or
Bill Szablewski, 609-252-5894
william.szablewski@bms.com
or
Department of Chemistry at Princeton University
Media:
Tien Nguyen, 609-258-6523
tienn@princeton.edu

Keywords: Responsible Business & Employee Engagement | Bristol-Myers Squibb | Health & Healthcare | Innovation | Innovation & Technology | Molecular Synthesis | Princeton University | Research | Responsible Production & Consumption | Science | Synthetic Chemistry

CAMPAIGN: Advancing Science Through Research

CONTENT: Press Release

parse.ly